Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression is a research paper published in Movement Disorders (2021). On theSindex it has a DataRank of 0. It has been cited 237 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph â no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full â never from an abstract alone.
Barts Charity
Grant: MGU0364
National Institute for Health Research (NIHR)
Grant: ACF-2018-19-004
Barts Charity
Grant: G-002047
Intramural NIH HHS
Grant: Z99 AG999999
Fonds de Recherche du Québec - Santé
Fonds de recherche du Québec-Santé (FRQS)
Young Investigator Award by Parkinson Canada
Canada First Research Excellence Fund
Canada First Research Excellence Fund (CFREF)
Michael J. Fox Foundation for Parkinson's Research
The Barts Charity
Intramural Research Program of the NIH, National Institute on Aging
Michael J. Fox Foundation
Canadian Consortium on Neurodegeneration in Aging (CCNA)
FWCI
17.12
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Causal relationship between diabetes mellitus, glycemic traits and Parkinsonâs disease: a multivariable mendelian randomization analysis
Additional file 1 of Causal relationship between diabetes mellitus, glycemic traits and Parkinsonâs disease: a multivariable mendelian randomization analysis
Additional file 1 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 1 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 2 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 2 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 3 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 3 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 4 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 4 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 5 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 5 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 6 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 6 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 7 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis
Additional file 7 of Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis